please browse and enjoy yourself!
Pharma Company Funding Anti-Pot Fight Worried About Losing Business, Filings Show
"... Insys filed a disclosure statement with the Securities and Exchange Commission stating plainly that legal marijuana is a direct threat to their product line:
Legalization of marijuana or non-synthetic cannabinoids
in the United States could significantly limit the commercial success of
any dronabinol product candidate. … If marijuana or non-synthetic
cannabinoids were legalized in the United States, the market for
dronabinol product sales would likely be significantly reduced and our
ability to generate revenue and our business prospects would be
materially adversely affected. ..."
